Pancreatic Cancer Research

ResearcherShandong UniversityActive in the last 2 years

Linlin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2033-9277; OpenAlex author ID A5100348981. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Interaction between Maslinic acid and HSF1 enhances the ubiquitin degradation of HSF1, resulting in the inhibitory effect of pancreatic cancer. Co-author DOI 10.1007/s12672-025-02786-8↗
  2. Effect of baicalin on proliferation and apoptosis in pancreatic cancer cells. Co-author PMID 31632536↗
  3. Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review. Last author DOI 10.3748/wjg.v23.i41.7478↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Li Cheng · 1 shared paper, 2025 · strength 0.27
  2. Xiukun Lin · 1 shared paper, 2025 · strength 0.27
  3. Ammad Ahmad Farooqı · 1 shared paper, 2025 · strength 0.27
  4. Congcheng Fang · 1 shared paper, 2019 · strength 0.10
  5. Qin Huang · 1 shared paper, 2019 · strength 0.10
  6. Cheng-Ming Li · 1 shared paper, 2017 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.